Table 2.
Significantly differentiated regions
| Discovery mechanism | Chr | Start (Mb) | End (Mb) | FST (window size) | XP-EHH (direction a ) | iHS (INS) | iHS (GIH) | Genes |
|---|---|---|---|---|---|---|---|---|
|
F
ST
|
4 |
17.0 |
17.5 |
Top 0.1% (500 kb) |
No evidence |
No evidence |
Top 1% |
QDPR, FAM184B, CLRN2, DCAF16, LAP3, MED28 |
| |
5 |
105.4 |
105.7 |
Top 0.1% (100 kb) |
Top 0.5% (negative) |
No evidence |
No evidence |
- |
| |
8 |
85.0 |
85.6 |
Top 0.1% (500 kb) |
Top 0.5% (negative) |
No evidence |
No evidence |
RALYL |
| |
15 |
45.7 |
46.2 |
Top 0.1% (500 kb) |
Top 0.5% (negative) |
No evidence |
No evidence |
SLC24A5, MYEF2, CTXN2, SLC12A1 |
| |
17 |
41.3 |
41.5 |
Top 0.1% (100 kb) |
Top 0.5% (positive) |
No evidence |
No evidence |
MAPT, STH, KIAA1267 |
|
iHS |
12 |
23.0 |
23.3 |
Top 1% (100 kb) |
No evidence |
No evidence |
Top 0.1% |
- |
| |
12 |
58.3 |
58.6 |
No evidence |
Top 0.5% (negative) |
No evidence |
Top 0.1% |
SLC16A7 |
| 12 | 80.3 | 80.6 | Top 1% (100 kb) | No evidence | Top 0.1% | No evidence | ACSS3, PPFIA2 |
Regions identified and validated across the genome by different discovery mechanisms using three population genetics metrics calculated from the data for GIH and INS.
aPositive direction indicates evidence of positive selection in INS while negative direction indicates evidence of positive selection in GIH.